Research Use
Also known as Growth Hormone Releasing Peptide-6

Function

Primary
GH secretagogue · Appetite stimulation
Secondary
Body composition
Mechanism
GHS-R1a agonist — stimulates GH release; pronounced ghrelin-like appetite stimulation; gastroprotective properties.
Evidence
Pre-clinical / Observational
Research
Pre-clinical and observational; limited Phase I

Dosing

Range
100–300 mcg/dose
Frequency
1–3× daily
Route
Subcutaneous

Cycling

8–12 weeks on / 4 weeks off.

Benefits

  • ·Appetite support in wasting states
  • ·GH release
  • ·Gastroprotective in models

Risks

  • ·Strong hunger stimulation
  • ·Cortisol and prolactin elevation
  • ·Desensitization

Contraindications

  • ·Active malignancy
  • ·Pregnancy

Regulatory

Not FDA-approved; research use

Functional Groups

Cited Works

  1. Locatelli V, Torsello A. GHRP-6 review. Curr Pharm Des. 2004;10:2255.
Sign in to save favorites & stacks